The High Quality of Global Clinical Trials

The High Quality of Global Clinical Trials

04.29.11 | By

Douglas Peddicord, Ph.D., has an interesting blog post on the high quality of clinical trials conducted around the world in the Huffington Post.

Dr. Peddicord, Executive Director of the Association of Clinical Research Organizations, makes three key points. First, clinical trials conducted around the globe and not just in the U.S. are important because "population translates to speed." In other words "greater population = faster clinical trials = new treatments available sooner."

Second, and critically, the quality of clinical trials whether done here in the U.S. or in other parts of the world is "equal." As he points out: "a third-party analysis concluded that there are no statistically significant differences in the quality of research data between or among countries and regions." This means that both America patients and patients around the world participating in clinical trials benefit from the high quality of medical care provided to participants.

Third, regulation continues to evolve, but claims that research conducted outside of the U.S. "adheres to lower ethical standards is ...a claim that is rarely accompanied by any supporting data." In other words, patients participating in clinical trials around the world are receiving both high quality care and are being treated ethically by researchers.

For more information about clinical trials and interactions with health care professionals, take a look at PhRMA's Principles for the Conduct of Clinical Trials and Code on Interactions with Health Care Professionals.

In addition, while Dr. Peddicord is mostly writing about research into medicines with broad application to patients around the world, check out Global Health Progress to learn more about efforts by biopharmaceutical research companies to research and develop medicines to help treat conditions found mostly in the developing world.

More On PhRMA — powered by PhRMApedia


Cost in Context